Analysts Set Reckitt Benckiser Group Plc (RB) Target Price at $7,961.82

Shares of Reckitt Benckiser Group Plc (LON:RB) have earned an average rating of “Buy” from the twenty-four research firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have issued a buy rating on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is GBX 8,086.82 ($103.03).

RB has been the topic of a number of research analyst reports. Jefferies Group LLC restated a “buy” rating and issued a GBX 8,000 ($101.92) price target on shares of Reckitt Benckiser Group Plc in a research note on Friday, April 28th. J P Morgan Chase & Co increased their price target on Reckitt Benckiser Group Plc from GBX 6,750 ($86.00) to GBX 7,250 ($92.37) and gave the company a “neutral” rating in a research note on Monday, May 8th. Barclays PLC dropped their price target on Reckitt Benckiser Group Plc from GBX 7,230 ($92.11) to GBX 7,100 ($90.46) and set an “equal weight” rating on the stock in a research note on Wednesday, April 26th. Kepler Capital Markets reiterated a “buy” rating and set a GBX 8,100 ($103.20) price objective on shares of Reckitt Benckiser Group Plc in a research report on Wednesday, March 22nd. Finally, Berenberg Bank reiterated a “buy” rating and set a GBX 8,500 ($108.29) price objective on shares of Reckitt Benckiser Group Plc in a research report on Monday, May 15th.

TRADEMARK VIOLATION NOTICE: This article was originally posted by BBNS and is the property of of BBNS. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://baseballnewssource.com/markets/analysts-set-reckitt-benckiser-group-plc-rb-price-target-at-7961-82-updated-updated-updated/804144.html.

Reckitt Benckiser Group Plc (LON:RB) traded up 0.72% during midday trading on Monday, hitting GBX 7982.00. 533,834 shares of the stock traded hands. The company has a 50-day moving average price of GBX 7,667.97 and a 200-day moving average price of GBX 7,201.41. Reckitt Benckiser Group Plc has a 1-year low of GBX 6,496.00 and a 1-year high of GBX 8,110.43. The firm’s market cap is GBX 55.88 billion.

In other Reckitt Benckiser Group Plc news, insider Adrian Bellamy bought 554 shares of the stock in a transaction on Friday, May 19th. The stock was acquired at an average cost of GBX 7,607 ($96.92) per share, for a total transaction of £42,142.78 ($53,691.91). Also, insider Rakesh Kapoor sold 58,094 shares of Reckitt Benckiser Group Plc stock in a transaction that occurred on Friday, May 5th. The stock was sold at an average price of GBX 7,150 ($91.09), for a total value of £4,153,721 ($5,292,038.48).

About Reckitt Benckiser Group Plc

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA, DvM and Food. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Receive News & Ratings for Reckitt Benckiser Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group Plc and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.